Pancreatic Cancer Research

ResearcherNanjing General Hospital of Nanjing Military CommandActive in the last 2 years

Daojun Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-4766-6976; OpenAlex author ID A5031773720. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability. Co-author DOI 10.1186/s40001-026-03963-3↗
  2. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Mo… Co-author DOI 10.1097/mpa.0000000000001806↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Rongxi Shen · 2 shared papers, 2021–2026 · strength 0.67
  2. Min Li · 1 shared paper, 2026 · strength 0.50
  3. Xinbo Wang · 1 shared paper, 2021 · strength 0.17
  4. Sizhen Wang · 1 shared paper, 2021 · strength 0.17
  5. Min Li · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.